0001720959-19-000002.txt : 20190906 0001720959-19-000002.hdr.sgml : 20190906 20190906145243 ACCESSION NUMBER: 0001720959-19-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190906 DATE AS OF CHANGE: 20190906 EFFECTIVENESS DATE: 20190906 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neumentum, Inc. CENTRAL INDEX KEY: 0001720959 IRS NUMBER: 821679493 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-335830 FILM NUMBER: 191079415 BUSINESS ADDRESS: STREET 1: 252 COLORADO AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 9082396142 MAIL ADDRESS: STREET 1: 252 COLORADO AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 D/A 1 primary_doc.xml X0708 D/A LIVE 0001720959 Neumentum, Inc. 252 COLORADO AVENUE PALO ALTO CA CALIFORNIA 94301 908-239-6142 DELAWARE None None Corporation true 2017 Richard Scott Shively c/o Neumentum, Inc. 252 Colorado Avenue Palo Alto CA CALIFORNIA 94301 Executive Officer Director Joseph Pergolizzi c/o Neumentum, Inc. 252 Colorado Avenue Palo Alto CA CALIFORNIA 94301 Director Christine Mikail Cvijic c/o Neumentum, Inc. 252 Colorado Avenue Palo Alto CA CALIFORNIA 94301 Executive Officer Director Pedro Granadillo c/o Neumentum, Inc. 252 Colorado Avenue Palo Alto CA CALIFORNIA 94301 Director Ilona Steigerwald c/o Neumentum, Inc. 252 Colorado Avenue Palo Alto CA CALIFORNIA 94301 Executive Officer August Moretti c/o Neumentum, Inc. 252 Colorado Avenue Palo Alto CA CALIFORNIA 94301 Director Pharmaceuticals Decline to Disclose 06b true 0001720959-19-000001 2019-03-12 false true true false 0 CIM Securities, LLC 120852 None None 275 Madison Avenue 39th Floor New York NY NEW YORK 10016 CA CALIFORNIA CT CONNECTICUT FL FLORIDA IL ILLINOIS MD MARYLAND MA MASSACHUSETTS NV NEVADA NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA SC SOUTH CAROLINA TX TEXAS WY WYOMING false Arcadia Securities, LLC 44656 None None 1370 Avenue of the Americas 29th Floor New York NY NEW YORK 10019 CA CALIFORNIA CO COLORADO FL FLORIDA NY NEW YORK PA PENNSYLVANIA WA WASHINGTON false 7000000 3020000 3980000 No additional convertible notes are expected to be sold and the offering will expire on its terms on September 8, 2019. false 36 420000 true 0 Commissions are a % of the total offering. Agent shall also receive a 7 yr warrant for 7% of the number of shares into which securities sold in the offering convert (or, a cash fee of 7% of the purchase price for the securities.) 930000 true The amount reflected in this Item 16 includes only salary and consulting payments the Issuer anticipates making to the executive officers and certain directors listed in Item 3, and assumes the Company raises the entire $7MM. false Neumentum, Inc. R. Scott Shively R. Scott Shively Chief Executive Officer 2019-09-06